78 related articles for article (PubMed ID: 24931875)
1. The depletion of securin enhances butein-induced apoptosis and tumor inhibition in human colorectal cancer.
Huang YT; Lin CI; Chien PH; Tang TT; Lin J; Chao JI
Chem Biol Interact; 2014 Sep; 220():41-50. PubMed ID: 24931875
[TBL] [Abstract][Full Text] [Related]
2. Depletion of securin increases arsenite-induced chromosome instability and apoptosis via a p53-independent pathway.
Chao JI; Hsu SH; Tsou TC
Toxicol Sci; 2006 Mar; 90(1):73-86. PubMed ID: 16338954
[TBL] [Abstract][Full Text] [Related]
3. Butein induces G(2)/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation.
Moon DO; Kim MO; Choi YH; Hyun JW; Chang WY; Kim GY
Cancer Lett; 2010 Feb; 288(2):204-13. PubMed ID: 19643530
[TBL] [Abstract][Full Text] [Related]
4. Butein induces apoptosis and inhibits prostate tumor growth in vitro and in vivo.
Khan N; Adhami VM; Afaq F; Mukhtar H
Antioxid Redox Signal; 2012 Jun; 16(11):1195-204. PubMed ID: 22114764
[TBL] [Abstract][Full Text] [Related]
5. Butein induces apoptosis in human uveal melanoma cells through mitochondrial apoptosis pathway.
Cui Z; Song E; Hu DN; Chen M; Rosen R; McCormick SA
Curr Eye Res; 2012 Aug; 37(8):730-9. PubMed ID: 22578288
[TBL] [Abstract][Full Text] [Related]
6. Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells.
Chiu SJ; Hsu TS; Chao JI
Toxicol Lett; 2006 Dec; 167(2):122-30. PubMed ID: 17045763
[TBL] [Abstract][Full Text] [Related]
7. Butein suppresses hepatocellular carcinoma growth via modulating Aurora B kinase activity.
Zhou Y; Li M; Yu X; Liu T; Li T; Zhou L; Liu W; Li W; Gao F
Int J Biol Sci; 2018; 14(11):1521-1534. PubMed ID: 30263005
[TBL] [Abstract][Full Text] [Related]
8. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo.
Rajendran P; Ong TH; Chen L; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Hui KM; Sethi G
Clin Cancer Res; 2011 Mar; 17(6):1425-39. PubMed ID: 21131551
[TBL] [Abstract][Full Text] [Related]
9. Butein, a novel dual inhibitor of MET and EGFR, overcomes gefitinib-resistant lung cancer growth.
Jung SK; Lee MH; Lim DY; Lee SY; Jeong CH; Kim JE; Lim TG; Chen H; Bode AM; Lee HJ; Lee KW; Dong Z
Mol Carcinog; 2015 Apr; 54(4):322-31. PubMed ID: 24974831
[TBL] [Abstract][Full Text] [Related]
10. Potential of butein, a tetrahydroxychalcone to obliterate cancer.
Padmavathi G; Rathnakaram SR; Monisha J; Bordoloi D; Roy NK; Kunnumakkara AB
Phytomedicine; 2015 Dec; 22(13):1163-71. PubMed ID: 26598915
[TBL] [Abstract][Full Text] [Related]
11. Butein suppresses breast cancer growth by reducing a production of intracellular reactive oxygen species.
Cho SG; Woo SM; Ko SG
J Exp Clin Cancer Res; 2014 Jun; 33(1):51. PubMed ID: 24919544
[TBL] [Abstract][Full Text] [Related]
12. Butein suppresses c-Myc-dependent transcription and Akt-dependent phosphorylation of hTERT in human leukemia cells.
Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
Cancer Lett; 2009 Dec; 286(2):172-9. PubMed ID: 19560862
[TBL] [Abstract][Full Text] [Related]
13. The blockage of survivin and securin expression increases the cytochalasin B-induced cell death and growth inhibition in human cancer cells.
Chao JI; Liu HF
Mol Pharmacol; 2006 Jan; 69(1):154-64. PubMed ID: 16219911
[TBL] [Abstract][Full Text] [Related]
14. Expression of securin promotes colorectal cancer cell death via a p53-independent pathway after radiation.
Chiu SJ; Hsu TS; Chao JI
Chem Biol Interact; 2007 Dec; 170(3):153-61. PubMed ID: 17854787
[TBL] [Abstract][Full Text] [Related]
15. Butein sensitizes human leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis inducing ligand (TRAIL).
Kim N
Arch Pharm Res; 2008 Sep; 31(9):1179-86. PubMed ID: 18806962
[TBL] [Abstract][Full Text] [Related]
16. Evidence of securin-mediated resistance to gefitinib-induced apoptosis in human cancer cells.
Yu SY; Liu HF; Wang SP; Chang CC; Tsai CM; Chao JI
Chem Biol Interact; 2013 Apr; 203(2):412-22. PubMed ID: 23523951
[TBL] [Abstract][Full Text] [Related]
17. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer.
Li Y; Zhao H; Wang Y; Zheng H; Yu W; Chai H; Zhang J; Falck JR; Guo AM; Yue J; Peng R; Yang J
Toxicol Appl Pharmacol; 2013 Oct; 272(1):37-48. PubMed ID: 23747687
[TBL] [Abstract][Full Text] [Related]
18. Butein induces intrinsic pathway of apoptosis, vimentin proteolysis, and inhibition of cancer stem cell population in a human papillary thyroid cancer cell line.
Tripathi D; Kulkarni S
Toxicol In Vitro; 2021 Dec; 77():105244. PubMed ID: 34481015
[TBL] [Abstract][Full Text] [Related]
19. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells.
Chua AW; Hay HS; Rajendran P; Shanmugam MK; Li F; Bist P; Koay ES; Lim LH; Kumar AP; Sethi G
Biochem Pharmacol; 2010 Nov; 80(10):1553-62. PubMed ID: 20699088
[TBL] [Abstract][Full Text] [Related]
20. Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells.
Moon DO; Choi YH; Moon SK; Kim WJ; Kim GY
Toxicol In Vitro; 2010 Oct; 24(7):1927-34. PubMed ID: 20696233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
